Table 1 Characteristics of enrolled patients (n = 44) at the hospital admission (t0) and discharge (td).
Characteristics | Hospital admission (t0) | Hospital discharge (td) | p-value |
|---|---|---|---|
Age (years) | 72 [16] | ||
Weight (Kg) | 77 ± 20 | 72 ± 16 | 0.14 |
Body mass index (Kg/m2) | 30 ± 6 | 26 ± 4 | 0.22 |
Heart failure severity NYHA class at admission | |||
NYHA I | 4 (9%) | ||
NYHA II | 8 (18%) | ||
NYHA III | 18 (41%) | ||
NYHA IV | 14 (32%) | ||
Systolic blood pressure (mmHg) | 123 ± 20 | 119 ± 18 | 0.39 |
Diastolic blood pressure (mmHg) | 75 ± 14 | 68 ± 13 | 0.07 |
Heart rate (bpm) | 75 [26] | 70 [17] | 0.16 |
Respiratory rate (breathes per minute) | 20 ± 8 | 16 ± 5 | 0.11 |
Left ventricular ejection fraction (%) | 31 [13] | 52 [12] | 0.01 |
Low-density lipoprotein (mg/dL) | 85 [59] | 76 [52] | 0.69 |
High-density lipoprotein (mg/dL) | 42 ± 13 | 43 ± 12 | 0.79 |
Triglyceride (mg/dL) | 93 [54] | 92 [46] | 0.77 |
Total calcium (mg/dL) | 9 ± 1 | 9 ± 1 | 0.84 |
Sodium (mmol/L) | 141 ± 7 | 139 ± 6 | 0.44 |
Potassium (mmol/L) | 4 ± 1 | 4 ± 1 | 0.37 |
Haemoglobin (g/dL) | 15 ± 2 | 13 ± 2 | 0.91 |
Haematocrit (%) | 39 ± 6 | 38 ± 7 | 0.78 |
White blood cell count (×109/L) | 8 [4] | 5 [2] | 0.02 |
Creatinine (mg/dL) | 1.5 [0.5] | 0.8 [0.5] | 0.38 |
Estimated glomerular filtration rate (mL/min) | 59 ± 23 | 57 ± 25 | 0.77 |
Blood NT-proBNP (pg/mL) | 1150 [1660] | 510 [1220] | 0.01 |
Alanine aminotransferase (U/L) | 23 [21] | 19 [12] | 0.21 |
Aspartate aminotransferase (U/L) | 20 [33] | 19 [22] | 0.69 |
Oxygen saturation (%) | 92 ± 4 | 98 ± 3 | 0.18 |
Glycaemia (mg/dL) | 110 [51] | 98 [42] | 0.18 |
Glycated haemoglobin (mmol/mol) | 48 [5] | 47 [6] | 0.97 |
Salivary pH | 6.9 ± 0.6 | 7.1 ± 0.5 | 0.75 |
Salivary flow rate (mL/min) | 0.5 [0.5] | 0.7 [0.3] | 0.09 |
Salivary lactate (μM) | 1670 [3160] | 620 [1030] | <0.01 |
Salivary uric acid (mg/mL) | 95 [110] | 55 [50] | 0.02 |
Salivary TNF-α (pg/mL) | 25 [45] | 20 [30] | 0.42 |
Salivary cortisol (pg/mL) | 760 [1560] | 720 [1280] | 0.07 |
Salivary α-amylase (U/mL) | 480 [470] | 400 [450] | 0.78 |
Salivary 8-isoPGF2α (pg/mL) | 40 [30] | 25 [21] | 0.02 |